These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15695812)

  • 1. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.
    Hoashi T; Watabe H; Muller J; Yamaguchi Y; Vieira WD; Hearing VJ
    J Biol Chem; 2005 Apr; 280(14):14006-16. PubMed ID: 15695812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers.
    Hoashi T; Muller J; Vieira WD; Rouzaud F; Kikuchi K; Tamaki K; Hearing VJ
    J Biol Chem; 2006 Jul; 281(30):21198-21208. PubMed ID: 16682408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.
    Hoashi T; Sato S; Yamaguchi Y; Passeron T; Tamaki K; Hearing VJ
    FASEB J; 2010 May; 24(5):1616-29. PubMed ID: 20056711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.
    Watabe H; Valencia JC; Le Pape E; Yamaguchi Y; Nakamura M; Rouzaud F; Hoashi T; Kawa Y; Mizoguchi M; Hearing VJ
    J Invest Dermatol; 2008 Jan; 128(1):162-74. PubMed ID: 17687388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
    De Mazière AM; Muehlethaler K; van Donselaar E; Salvi S; Davoust J; Cerottini JC; Lévy F; Slot JW; Rimoldi D
    Traffic; 2002 Sep; 3(9):678-93. PubMed ID: 12191019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coat color dilution in mice because of inactivation of the melanoma antigen MART-1.
    Aydin IT; Hummler E; Smit NP; Beermann F
    Pigment Cell Melanoma Res; 2012 Jan; 25(1):37-46. PubMed ID: 21943097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function.
    Theos AC; Truschel ST; Raposo G; Marks MS
    Pigment Cell Res; 2005 Oct; 18(5):322-36. PubMed ID: 16162173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv.
    Kawakami A; Sakane F; Imai S; Yasuda S; Kai M; Kanoh H; Jin HY; Hirosaki K; Yamashita T; Fisher DE; Jimbow K
    J Invest Dermatol; 2008 Jan; 128(1):143-50. PubMed ID: 17625594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premelanosome amyloid-like fibrils are composed of only golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes.
    Harper DC; Theos AC; Herman KE; Tenza D; Raposo G; Marks MS
    J Biol Chem; 2008 Jan; 283(4):2307-22. PubMed ID: 17991747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum export, subcellular distribution, and fibril formation by Pmel17 require an intact N-terminal domain junction.
    Leonhardt RM; Vigneron N; Rahner C; Van den Eynde BJ; Cresswell P
    J Biol Chem; 2010 May; 285(21):16166-83. PubMed ID: 20231267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced glutathione disrupts the intracellular trafficking of tyrosinase and tyrosinase-related protein-1 but not dopachrome tautomerase and Pmel17 to melanosomes, which results in the attenuation of melanization.
    Nakajima H; Nagata T; Koga S; Imokawa G
    Arch Dermatol Res; 2014 Jan; 306(1):37-49. PubMed ID: 23764898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes.
    Kawaguchi M; Hozumi Y; Suzuki T
    J Dermatol Sci; 2015 May; 78(2):133-42. PubMed ID: 25818872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition.
    Giordano F; Bonetti C; Surace EM; Marigo V; Raposo G
    Hum Mol Genet; 2009 Dec; 18(23):4530-45. PubMed ID: 19717472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment.
    Yasumoto K; Watabe H; Valencia JC; Kushimoto T; Kobayashi T; Appella E; Hearing VJ
    J Biol Chem; 2004 Jul; 279(27):28330-8. PubMed ID: 15096515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes.
    Robila V; Ostankovitch M; Altrich-Vanlith ML; Theos AC; Drover S; Marks MS; Restifo N; Engelhard VH
    J Immunol; 2008 Dec; 181(11):7843-52. PubMed ID: 19017974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance decreases with mutations of melanosomal regulatory genes.
    Xie T; Nguyen T; Hupe M; Wei ML
    Cancer Res; 2009 Feb; 69(3):992-9. PubMed ID: 19155314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex.
    Sprong H; Degroote S; Claessens T; van Drunen J; Oorschot V; Westerink BH; Hirabayashi Y; Klumperman J; van der Sluijs P; van Meer G
    J Cell Biol; 2001 Oct; 155(3):369-80. PubMed ID: 11673476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for melanosome biogenesis based on the purification and analysis of early melanosomes.
    Kushimoto T; Basrur V; Valencia J; Matsunaga J; Vieira WD; Ferrans VJ; Muller J; Appella E; Hearing VJ
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10698-703. PubMed ID: 11526213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
    Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
    J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo.
    Cormier JN; Hijazi YM; Abati A; Fetsch P; Bettinotti M; Steinberg SM; Rosenberg SA; Marincola FM
    Int J Cancer; 1998 Feb; 75(4):517-24. PubMed ID: 9466650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.